Princeton Medical Review: Continuous Vital-Sign Monitoring: Preventing Opioid-Induced Respiratory Depression

September, 2025 article by Anthony Rice, Princeton Medical Review

RTM Vital Signs Receives FDA Clearance for its Respiratory Monitoring System (RMS)

Philadelphia, PA — July 22, 2025 — RTM Vital Signs, LLC, a leader in advanced respiratory monitoring, proudly announces that its 1st generation Respiratory Monitoring System (RMS GEN I) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) as a wearable device that continuously measures a patient’s respiratory rate. The RMS GEN […]

Opioid-Induced Respiratory Depression—Pediatric Considerations

By: Tricia Vecchione, MD, MPH; Constance L. Monitto, MD SUMMARY: Opioid-induced respiratory depression can be a life-threatening, albeit preventable, complication in children. It is imperative to identify those at risk for opioid-induced respiratory depression and formulate safer practices, including the use of opioid-sparing adjuncts, frequent sedation assessment and vigilant monitoring. Unfortunately, no models designed to […]

End of content

No more pages to load